Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Abstract Metastatic breast cancer is mostly incurable. Progressively overall survival (OS) has improved but few authors have studied treatment globally versus for each line and demonstrated the interest of chemotherapy (CT) after the third line. We selected recent patients treated during the “taxane...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast (Edinburgh) 2011-12, Vol.20 (6), p.574-578
Hauptverfasser:	Planchat, E, Abrial, C, Thivat, E, Mouret-Reynier, M.A, Kwiatkowski, F, Pomel, C, Wang-Lopez, Q, Chollet, P, Nabholtz, J.M, Durando, X
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - therapy Chemotherapy Combined Modality Therapy Decision Making Female France Hematology, Oncology and Palliative Medicine Humans Mastectomy Medical Oncology Metastatic breast Cancer Neoplasm Metastasis Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - therapy Neoplasm Staging Overall survival Practice Patterns, Physicians Retrospective Studies Survival Analysis Tumor Response
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!